evans blue has been researched along with cl 316243 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, MJ; Coleman, RA | 1 |
1 other study(ies) available for evans blue and cl 316243
Article | Year |
---|---|
Beta 2-adrenoceptors mediate a reduction in endothelial permeability in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albumins; Albuterol; Analysis of Variance; Animals; Capillary Permeability; Catechols; Cattle; Cells, Cultured; Dioxoles; Dose-Response Relationship, Drug; Endothelium, Vascular; Evans Blue; Hydrogen Peroxide; Isoproterenol; Lipopolysaccharides; Nitroprusside; Propanolamines; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Thrombin; Thromboxane A2; Vasoconstrictor Agents | 1995 |